Viewing Study NCT03363503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-01-16 @ 1:37 PM
Study NCT ID: NCT03363503
Status: TERMINATED
Last Update Posted: 2022-05-20
First Post: 2017-11-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD
Sponsor: Neutec Ar-Ge San ve Tic A.Ş
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COPD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COPD View
None Salmeterol/Fluticasone View
None Discair View
None Diskus View
None Spirometry View